Response to Is radiotherapy the best option for treating hepatocellular carcinoma with PVTT?
Jung Ho Im
Department of Radiation Oncology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
These authors contributed equally to this work as first authors.Search for more papers by this authorSang Min Yoon
Department of Radiation Oncology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
These authors contributed equally to this work as first authors.Search for more papers by this authorHee Chul Park
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, Korea
Search for more papers by this authorJong Hoon Kim
Department of Radiation Oncology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorJeong Il Yu
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, Korea
Search for more papers by this authorTae Hyun Kim
Center for Liver Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
Search for more papers by this authorJun Won Kim
Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Search for more papers by this authorTaek-Keun Nam
Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, Korea
Search for more papers by this authorKyubo Kim
Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea
Search for more papers by this authorHong Seok Jang
Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea
Search for more papers by this authorJin Hee Kim
Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea
Search for more papers by this authorMi-Sook Kim
Department of Radiation Oncology, Korea Institute Radiological & Medical Sciences, Seoul, Korea
Search for more papers by this authorWon Sup Yoon
Department of Radiation Oncology, Ansan Hospital, Korea University Medical Center, Ansan, Korea
Search for more papers by this authorInkyung Jung
Department of Biostatistics, Yonsei University College of Medicine, Seoul, Korea
Search for more papers by this authorCorresponding Author
Jinsil Seong
Department of Radiation Oncology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
E-mail: [email protected]Search for more papers by this authorJung Ho Im
Department of Radiation Oncology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
These authors contributed equally to this work as first authors.Search for more papers by this authorSang Min Yoon
Department of Radiation Oncology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
These authors contributed equally to this work as first authors.Search for more papers by this authorHee Chul Park
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, Korea
Search for more papers by this authorJong Hoon Kim
Department of Radiation Oncology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorJeong Il Yu
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, Korea
Search for more papers by this authorTae Hyun Kim
Center for Liver Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
Search for more papers by this authorJun Won Kim
Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Search for more papers by this authorTaek-Keun Nam
Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, Korea
Search for more papers by this authorKyubo Kim
Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea
Search for more papers by this authorHong Seok Jang
Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea
Search for more papers by this authorJin Hee Kim
Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea
Search for more papers by this authorMi-Sook Kim
Department of Radiation Oncology, Korea Institute Radiological & Medical Sciences, Seoul, Korea
Search for more papers by this authorWon Sup Yoon
Department of Radiation Oncology, Ansan Hospital, Korea University Medical Center, Ansan, Korea
Search for more papers by this authorInkyung Jung
Department of Biostatistics, Yonsei University College of Medicine, Seoul, Korea
Search for more papers by this authorCorresponding Author
Jinsil Seong
Department of Radiation Oncology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
E-mail: [email protected]Search for more papers by this author
References
- 1Yin J, Xin L, Zhang P, Lang JY. Is radiotherapy the best option for treating hepatocellular carcinoma with PVTT? Liver Int 2017; 37: 307–308.
- 2Im JH, Yoon SM, Park HC, et al. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area. Liver Int 2017; 37: 90–100.
- 3Shuqun C, Mengchao W, Han C, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology. 2007; 54: 499–502.
Citing Literature
